Nonalcoholic steatohepatitis (NASH) is a progressive liver disease with no approved treatment. Resmetirom is an oral, liver-directed, thyroid hormone receptor beta–selective agonist in development for ...
When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...
Elemento is the director of the Englander Institute for Precision Medicine at Weill Cornell Medicine. Sternberg is the clinical director of the Englander Institute for Precision Medicine. Khozin is ...
However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...
News-Medical.Net on MSN
New global guidelines improve reporting of pediatric randomized controlled trials
Researchers at The Hospital for Sick Children (SickKids), working with international collaborators and youth and family ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results